QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (33) Citing Articles via Google Scholar Google Scholar Articles by Oh, L. Y. S. Articles by Bansal, R. Search for Related Content PubMed PubMed Citation Articles by Oh, L. Y. S. Articles by Bansal, R.

 Previous Article  |  Next Article 

The Journal of Neuroscience, February 1, 2003, 23(3):883

Fibroblast Growth Factor Receptor 3 Signaling Regulates the Onset of Oligodendrocyte Terminal Differentiation

Luke Y. S. Oh¹, Adam Denninger¹, Jennifer S. Colvin³, Aditee Vyas², Shubha Tole², David M. Ornitz³, and Rashmi Bansal¹

¹ Department of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut 06030, ² Department of Biological Sciences, Tata Institute of Fundamental Research, Mumbai, 400 005 India, and ³ Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110

Fibroblast growth factor receptor (FGFR) signaling is essential for nervous system development. We have shown that, in the normal postnatal brain, the spatial and temporal expression pattern of FGFR3 parallels the appearance of differentiated oligodendrocytes and that in culture FGFR3 is expressed maximally at the critical stage in the lineage at which oligodendrocyte late progenitors (Pro-OLs) enter terminal differentiation. Therefore, FGFR3 expression is positioned ideally to have an impact on oligodendrocyte differentiation. In support of this we show that, during the onset and active phase of myelination in FGFR3-deficient mice, there are reduced numbers of differentiated oligodendrocytes in the forebrain, cerebellum, hindbrain, and spinal cord. Furthermore, myelination is delayed in parallel. Delay of oligodendrocyte differentiation also is observed in primary cell culture from this mutant. On the other hand, no differences are observed in the survival or proliferation of oligodendrocyte progenitors. This suggests that the decrease in the number of differentiated oligodendrocytes is attributable to a delay in the timing of their differentiation process. Astrocytes also express FGFR3, and in mice lacking FGFR3 there is an enhancement of the astrocytic marker glial fibrillary acidic protein expression in a region-specific manner. Thus our findings suggest that there are cell type- and region-specific functions for FGFR3 signaling and in particular emphasize a prominent role for FGFR3 as part of a system regulating the onset of oligodendrocyte terminal differentiation.

Key words: oligodendrocyte; myelin; FGF; astrocyte; cerebellar neuron; FGF receptor

---

Copyright © 2003 Society for Neuroscience  0270-6474/03/233883-12$05.00/0

This article has been cited by other articles:

				G. Galabova-Kovacs, F. Catalanotti, D. Matzen, G. X. Reyes, J. Zezula, R. Herbst, A. Silva, I. Walter, and M. Baccarini Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development J. Cell Biol., March 5, 2008; 180(5): 947 - 955. [Abstract] [Full Text] [PDF]

				M. Timmer, K. Cesnulevicius, C. Winkler, J. Kolb, E. Lipokatic-Takacs, J. Jungnickel, and C. Grothe Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion J. Neurosci., January 17, 2007; 27(3): 459 - 471. [Abstract] [Full Text] [PDF]

				S. Arnaud-Dabernat, M. Kritzik, A. G. Kayali, Y.-Q. Zhang, G. Liu, C. Ungles, and N. Sarvetnick FGFR3 Is a Negative Regulator of the Expansion of Pancreatic Epithelial Cells Diabetes, January 1, 2007; 56(1): 96 - 106. [Abstract] [Full Text] [PDF]

				Y. Kaga, W. J. Shoemaker, M. Furusho, M. Bryant, J. Rosenbluth, S. E. Pfeiffer, L. Oh, M. Rasband, C. Lappe-Siefke, K. Yu, et al. Mice with Conditional Inactivation of Fibroblast Growth Factor Receptor-2 Signaling in Oligodendrocytes Have Normal Myelin But Display Dramatic Hyperactivity when Combined with Cnp1 Inactivation. J. Neurosci., November 22, 2006; 26(47): 12339 - 12350. [Abstract] [Full Text] [PDF]

				G. Gutin, M. Fernandes, L. Palazzolo, H. Paek, K. Yu, D. M. Ornitz, S. K. McConnell, and J. M. Hebert FGF signalling generates ventral telencephalic cells independently of SHH Development, August 1, 2006; 133(15): 2937 - 2946. [Abstract] [Full Text] [PDF]

				D. Fortin, E. Rom, H. Sun, A. Yayon, and R. Bansal Distinct Fibroblast Growth Factor (FGF)/FGF Receptor Signaling Pairs Initiate Diverse Cellular Responses in the Oligodendrocyte Lineage J. Neurosci., August 10, 2005; 25(32): 7470 - 7479. [Abstract] [Full Text] [PDF]

				C. B. Marta, M. B. Montano, C. M. Taylor, A. L. Taylor, R. Bansal, and S. E. Pfeiffer Signaling Cascades Activated upon Antibody Cross-linking of Myelin Oligodendrocyte Glycoprotein: POTENTIAL IMPLICATIONS FOR MULTIPLE SCLEROSIS J. Biol. Chem., March 11, 2005; 280(10): 8985 - 8993. [Abstract] [Full Text] [PDF]

				C. Jaillard, S. Harrison, B. Stankoff, M. S. Aigrot, A. R. Calver, G. Duddy, F. S. Walsh, M. N. Pangalos, N. Arimura, K. Kaibuchi, et al. Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival J. Neurosci., February 9, 2005; 25(6): 1459 - 1469. [Abstract] [Full Text] [PDF]

				M. L. Speltz, K. A. Kapp-Simon, M. Cunningham, J. Marsh, and G. Dawson Single-Suture Craniosynostosis: A Review of Neurobehavioral Research and Theory J. Pediatr. Psychol., December 1, 2004; 29(8): 651 - 668. [Abstract] [Full Text] [PDF]

				E. M. Blalock, J. W. Geddes, K. C. Chen, N. M. Porter, W. R. Markesbery, and P. W. Landfield Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses PNAS, February 17, 2004; 101(7): 2173 - 2178. [Abstract] [Full Text] [PDF]

				B. L. Allen and A. C. Rapraeger Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly J. Cell Biol., November 10, 2003; 163(3): 637 - 648. [Abstract] [Full Text] [PDF]

				T. Lin, S. B. Sandusky, H. Xue, K. W. Fishbein, R. G. Spencer, M. S. Rao, and C. A. Francomano A central nervous system specific mouse model for thanatophoric dysplasia type II Hum. Mol. Genet., November 1, 2003; 12(21): 2863 - 2871. [Abstract] [Full Text] [PDF]

				J. Imitola, E. Y. Snyder, and S. J. Khoury Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis Physiol Genomics, August 15, 2003; 14(3): 171 - 197. [Abstract] [Full Text] [PDF]

				M. R. Bennett, T. A. Rizvi, S. Karyala, R. D. McKinnon, and N. Ratner Aberrant Growth and Differentiation of Oligodendrocyte Progenitors in Neurofibromatosis Type 1 Mutants J. Neurosci., August 6, 2003; 23(18): 7207 - 7217. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help